Skip to content

Effect of reminiscence therapy on anxiety, depression and quality of life in elderly hepatocellular carcinoma patients

Effect of reminiscence therapy on anxiety, depression and quality of life in elderly hepatocellular carcinoma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058975
Enrollment
Unknown
Registered
2022-04-21
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Experimental group:The patient received recall therapy in the rehabilitation center of our hospital for 12 months
Control group:After discharge, the patient returned to our hospital every month to consult with doctors and exchange relevant knowledge of liver cancer treatment, nursing and recovery

Sponsors

The Central Hospital of Wuhan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with liver cancer; 2. Aged between 60 and 80 years; 3. CNLC stages Ia to IIb and is suitable for surgical resection; 4. No vascular invasion; 5. Cognitive function policy and ability to complete research assessment scale; 6. Voluntarily and actively cooperate with the evaluation of research indicators.

Exclusion criteria

Exclusion criteria: 1. Clinical diagnosis of anxiety or depression before enrollment; 2. With mental illness; 3. Difficulty communicating with others; 4. There are other malignancies.

Design outcomes

Primary

MeasureTime frame
anxiety rate;depression rate;

Secondary

MeasureTime frame
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30 Score;

Countries

China

Contacts

Public ContactWu Chang

The Central Hospital of Wuhan

jessdeng@qeejen.com+86 13761145675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026